Lobbying client
SYNEDGEN, INC.
Biomedical research and product development
Filings
13
Filed by
1
Reported in-house
—
Reported by firms
—
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2009 to 2012
Filings
13 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2012
|
DONALD MASSEY | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2012
|
DONALD MASSEY | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2011
|
DONALD MASSEY | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2011
|
DONALD MASSEY | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2011
|
DONALD MASSEY | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2011
|
DONALD MASSEY | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2010
|
DONALD MASSEY | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2010
|
DONALD MASSEY | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2010
|
DONALD MASSEY | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2010
|
DONALD MASSEY | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| DONALD MASSEY | 12 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Defense | DEF | 3 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| H.R. 3326 | 111th | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.